Trading of Apollomics Inc. shares and warrants halted pending additional information from the company.
Quiver AI Summary
On September 17, 2025, trading of Apollomics Inc., Ltd. was halted on the Nasdaq Stock Market at 14:37:17 Eastern Time due to a request for additional information from the company. At the time of the halt, the company's ordinary shares were last priced at $18.4331, while its warrants were priced at $0.0191. Trading will remain paused until Apollomics has provided the requested information to Nasdaq. For further details, individuals can contact the company directly or use the Nasdaq InfoQuotes feature.
Potential Positives
- Trading in Apollomics Inc., Ltd. shares has garnered significant attention due to the halt, indicating investor interest and engagement.
- The press release provides transparency regarding the reasons for the trading halt, which can help maintain investor trust and confidence.
- The announcement reflects Nasdaq's commitment to regulatory compliance and due diligence, which enhances the overall credibility of the market.
Potential Negatives
- Trading of Apollomics Inc., Ltd. was halted by Nasdaq due to a request for additional information, indicating potential concerns regarding the company’s compliance or disclosures.
- The halt in trading may negatively impact investor confidence and perception of the company's stability.
- The last sale price of the company’s ordinary shares was significantly lower than prior values, which could suggest declining investor interest or value.
FAQ
Why was trading halted for Apollomics Inc.?
Trading was halted to request additional information from the company on September 17, 2025.
What was the last sale price of Apollomics Inc. shares?
The last sale price of Apollomics Inc. ordinary shares was $18.4331.
What are the current prices for Apollomics Inc. warrants?
The current price for Apollomics Inc. warrants is $0.0191.
When will trading resume for Apollomics Inc.?
Trading will resume once Apollomics has fully satisfied Nasdaq’s request for additional information.
How can I get more information about Apollomics Inc.?
You can contact the company directly or check their symbol using InfoQuotes on the Nasdaq website.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$NDAQ Congressional Stock Trading
Members of Congress have traded $NDAQ stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $NDAQ stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$NDAQ Insider Trading Activity
$NDAQ insiders have traded $NDAQ stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $NDAQ stock by insiders over the last 6 months:
- BRADLEY J PETERSON (EVP, CIO) has made 0 purchases and 2 sales selling 13,816 shares for an estimated $1,197,362.
- MICHELLE LYNN DALY (SVP, Controller & PAO) sold 8,691 shares for an estimated $812,173
- JEREMY SKULE (EVP, CSO) has made 0 purchases and 5 sales selling 8,421 shares for an estimated $758,471.
- PC NELSON GRIGGS (Pres. Capital Access Platforms) has made 0 purchases and 2 sales selling 8,000 shares for an estimated $664,240.
- CHARLENE T BEGLEY sold 3,000 shares for an estimated $289,800
- BRYAN EVERARD SMITH (EVP, CPO) has made 0 purchases and 3 sales selling 3,789 shares for an estimated $284,257.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NDAQ Hedge Fund Activity
We have seen 570 institutional investors add shares of $NDAQ stock to their portfolio, and 428 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- THOMA BRAVO, L.P. removed 42,804,207 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,827,552,189
- WELLINGTON MANAGEMENT GROUP LLP added 8,507,606 shares (+26.0%) to their portfolio in Q2 2025, for an estimated $760,750,128
- JANE STREET GROUP, LLC added 7,187,313 shares (+40335.1%) to their portfolio in Q2 2025, for an estimated $642,689,528
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 6,840,735 shares (+33.5%) to their portfolio in Q2 2025, for an estimated $611,698,523
- CAPITAL WORLD INVESTORS removed 6,628,258 shares (-97.8%) from their portfolio in Q2 2025, for an estimated $592,698,830
- VANGUARD GROUP INC added 2,820,339 shares (+5.3%) to their portfolio in Q2 2025, for an estimated $252,194,713
- NEUBERGER BERMAN GROUP LLC added 1,946,479 shares (+261.7%) to their portfolio in Q2 2025, for an estimated $174,054,152
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NDAQ Analyst Ratings
Wall Street analysts have issued reports on $NDAQ in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 07/25/2025
- Keefe, Bruyette & Woods issued a "Outperform" rating on 07/25/2025
- Barclays issued a "Overweight" rating on 07/25/2025
- Deutsche Bank issued a "Buy" rating on 07/25/2025
- UBS issued a "Buy" rating on 07/25/2025
- Piper Sandler issued a "Overweight" rating on 07/15/2025
- Raymond James issued a "Outperform" rating on 07/09/2025
To track analyst ratings and price targets for $NDAQ, check out Quiver Quantitative's $NDAQ forecast page.
$NDAQ Price Targets
Multiple analysts have issued price targets for $NDAQ recently. We have seen 12 analysts offer price targets for $NDAQ in the last 6 months, with a median target of $104.0.
Here are some recent targets:
- Richard Repetto from Piper Sandler set a target price of $104.0 on 08/04/2025
- Ashish Sabadra from RBC Capital set a target price of $108.0 on 07/25/2025
- Alex Kramm from UBS set a target price of $115.0 on 07/25/2025
- Kyle Voigt from Keefe, Bruyette & Woods set a target price of $104.0 on 07/25/2025
- Brian Bedell from Deutsche Bank set a target price of $105.0 on 07/25/2025
- Benjamin Budish from Barclays set a target price of $109.0 on 07/25/2025
- Michael Cyprys from Morgan Stanley set a target price of $86.0 on 07/15/2025
Full Release
NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market ® (Nasdaq: NDAQ) announced that trading was halted on September 17, 2025 in Apollomics Inc., Ltd. at 14:37:17 Eastern Time for additional information requested from the company. The last sale price of the company’s ordinary shares was $18.4331 (Nasdaq: APLM), and warrants was $0.0191 (Nasdaq: APLMW).
Trading will remain halted until Apollomics Inc. has fully satisfied Nasdaq’s request for additional information.
For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotes SM on the Nasdaq ® Web site.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com .
Nasdaq Media Contact:
Sophia Weiss
[email protected]
NDAQO
